Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis

10.1371/journal.pone.0061568

Saved in:

Bibliographic Details
Main Authors:	Cozen M.L., Ryan J.C., Shen H., Lerrigo R., Yee R.M., Sheen E., Wu R., Monto A.
Other Authors:	MICROBIOLOGY AND IMMUNOLOGY
Format:	Article
Published:	2019
Subjects:	alpha interferon peginterferon alpha ribavirin adult aged article clinical assessment controlled study disease association drug treatment failure female follow up hepatitis C human human tissue liver biopsy liver cirrhosis liver fibrosis major clinical study male overall survival patient attitude retrospective study risk assessment risk factor treatment outcome complication disease course Hepatitis C, Chronic middle aged recurrent disease reproducibility survival time treatment failure Hepatitis C virus Aged Disease Progression Female Humans Interferon-alpha Liver Cirrhosis Male Middle Aged Recurrence Reproducibility of Results Retrospective Studies Risk Factors Survival Analysis Time Factors Treatment Failure
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/161328
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-161328
record_format	dspace
spelling	sg-nus-scholar.10635-1613282024-03-27T08:19:02Z Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis Cozen M.L. Ryan J.C. Shen H. Lerrigo R. Yee R.M. Sheen E. Wu R. Monto A. MICROBIOLOGY AND IMMUNOLOGY alpha interferon peginterferon alpha ribavirin alpha interferon adult aged article clinical assessment controlled study disease association drug treatment failure female follow up hepatitis C human human tissue liver biopsy liver cirrhosis liver fibrosis major clinical study male overall survival patient attitude retrospective study risk assessment risk factor treatment outcome complication disease course Hepatitis C, Chronic liver cirrhosis middle aged recurrent disease reproducibility survival time treatment failure Hepatitis C virus Aged Disease Progression Female Hepatitis C, Chronic Humans Interferon-alpha Liver Cirrhosis Male Middle Aged Recurrence Reproducibility of Results Retrospective Studies Risk Factors Survival Analysis Time Factors Treatment Failure 10.1371/journal.pone.0061568 PLoS ONE 8 4 e61568 2019-11-04T04:07:39Z 2019-11-04T04:07:39Z 2013 Article Cozen M.L., Ryan J.C., Shen H., Lerrigo R., Yee R.M., Sheen E., Wu R., Monto A. (2013). Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis. PLoS ONE 8 (4) : e61568. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0061568 19326203 https://scholarbank.nus.edu.sg/handle/10635/161328 Unpaywall 20191101
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	alpha interferon peginterferon alpha ribavirin alpha interferon adult aged article clinical assessment controlled study disease association drug treatment failure female follow up hepatitis C human human tissue liver biopsy liver cirrhosis liver fibrosis major clinical study male overall survival patient attitude retrospective study risk assessment risk factor treatment outcome complication disease course Hepatitis C, Chronic liver cirrhosis middle aged recurrent disease reproducibility survival time treatment failure Hepatitis C virus Aged Disease Progression Female Hepatitis C, Chronic Humans Interferon-alpha Liver Cirrhosis Male Middle Aged Recurrence Reproducibility of Results Retrospective Studies Risk Factors Survival Analysis Time Factors Treatment Failure
spellingShingle	alpha interferon peginterferon alpha ribavirin alpha interferon adult aged article clinical assessment controlled study disease association drug treatment failure female follow up hepatitis C human human tissue liver biopsy liver cirrhosis liver fibrosis major clinical study male overall survival patient attitude retrospective study risk assessment risk factor treatment outcome complication disease course Hepatitis C, Chronic liver cirrhosis middle aged recurrent disease reproducibility survival time treatment failure Hepatitis C virus Aged Disease Progression Female Hepatitis C, Chronic Humans Interferon-alpha Liver Cirrhosis Male Middle Aged Recurrence Reproducibility of Results Retrospective Studies Risk Factors Survival Analysis Time Factors Treatment Failure Cozen M.L. Ryan J.C. Shen H. Lerrigo R. Yee R.M. Sheen E. Wu R. Monto A. Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
description	10.1371/journal.pone.0061568
author2	MICROBIOLOGY AND IMMUNOLOGY
author_facet	MICROBIOLOGY AND IMMUNOLOGY Cozen M.L. Ryan J.C. Shen H. Lerrigo R. Yee R.M. Sheen E. Wu R. Monto A.
format	Article
author	Cozen M.L. Ryan J.C. Shen H. Lerrigo R. Yee R.M. Sheen E. Wu R. Monto A.
author_sort	Cozen M.L.
title	Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
title_short	Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
title_full	Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
title_fullStr	Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
title_full_unstemmed	Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
title_sort	nonresponse to interferon-? based treatment for chronic hepatitis c infection is associated with increased hazard of cirrhosis
publishDate	2019
url	https://scholarbank.nus.edu.sg/handle/10635/161328
_version_	1795300769047511040

Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis

Similar Items